T. Rowe Price Associates
VCEL icon

T. Rowe Price Associates’s Vericel Corp VCEL Stock Holding History

T. Rowe Price Associates’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Buy
62,743
+12,909
+26% +$459K ﹤0.01% 1815
2025
Q4 		$1.79M Buy
49,834
+5,745
+13% +$211K ﹤0.01% 1803
2025
Q3 		$1.39M Buy
44,089
+2,596
+6% +$93.2K ﹤0.01% 1905
2025
Q2 		$1.77M Buy
41,493
+4,529
+12% +$188K ﹤0.01% 1693
2025
Q1 		$1.65M Buy
36,964
+7,485
+25% +$403K ﹤0.01% 1702
2024
Q4 		$1.62M Sell
29,479
-868
-3% -$43.9K ﹤0.01% 1745
2024
Q3 		$1.28M Buy
30,347
+1,245
+4% +$59.2K ﹤0.01% 1862
2024
Q2 		$1.34M Buy
29,102
+1,822
+7% +$85.9K ﹤0.01% 1760
2024
Q1 		$1.42M Buy
27,280
+1,721
+7% +$75.4K ﹤0.01% 1735
2023
Q4 		$911K Buy
25,559
+170
+0.7% +$5.92K ﹤0.01% 1908
2023
Q3 		$852K Buy
25,389
+2,745
+12% +$95.2K ﹤0.01% 1870
2023
Q2 		$851K Buy
22,644
+563
+3% +$18.5K ﹤0.01% 1884
2023
Q1 		$648K Buy
22,081
+842
+4% +$24.4K ﹤0.01% 1997
2022
Q4 		$559K Buy
21,239
+596
+3% +$14.2K ﹤0.01% 2084
2022
Q3 		$479K Buy
20,643
+3,097
+18% +$84.5K ﹤0.01% 2146
2022
Q2 		$442K Sell
17,546
-2,307
-12% -$68.1K ﹤0.01% 2270
2022
Q1 		$759K Buy
19,853
+1,578
+9% +$56.9K ﹤0.01% 2143
2021
Q4 		$718K Sell
18,275
-3,719
-17% -$163K ﹤0.01% 2201
2021
Q3 		$1.07M Buy
21,994
+3,269
+17% +$169K ﹤0.01% 2033
2021
Q2 		$983K Buy
18,725
+758
+4% +$43.2K ﹤0.01% 2075
2021
Q1 		$998K Buy
+17,967
New +$813K ﹤0.01% 2046

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

T. Rowe Price Associates's VCEL Position: Q1 2026 in Review

T. Rowe Price Associates increased its Vericel Corp (VCEL) stake by 26% in Q1 2026, buying an estimated $459K and bringing the position to 62,743 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

T. Rowe Price Associates first reported a position in VCEL in Q1 2021 and has held it in 21 quarters since. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • T. Rowe Price Associates held 62,743 shares of Vericel Corp worth $2.02M as of Q1 2026.
  • T. Rowe Price Associates bought 12,909 Vericel Corp shares in Q1 2026, an estimated $459K.
  • Vericel Corp made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1815 holding.
  • T. Rowe Price Associates first reported a position in Vericel Corp in Q1 2021 and has held it in 21 quarters since.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.